Y Intercept (Hong Kong) LTD Lantheus Holdings, Inc. Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $620,784 - $875,762	-10,545 Reduced 58.37%	7,522 $603,000
Q1 2024 May 10, 2024	BUY	$51.07 - $68.26 $922,681 - $1.23 Million	18,067 New	18,067 $1.12 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $1.35 Million - $1.63 Million	16,356 New	16,356 $1.37 Million
Q4 2022 Feb 14, 2023	BUY	$48.76 - $77.67 $1.45 Million - $2.31 Million	29,725 Added 977.15%	32,767 $1.67 Million
Q3 2022 Feb 14, 2023	BUY	$61.42 - $86.29 $186,839 - $262,494	3,042 New	3,042 $213,000

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.